Ethylmethylthiambutene
 | |
| Systematic (IUPAC) name | |
|---|---|
| N-ethyl-N-methyl-4,4-dithiophen-2-yl-but-3-en-2-amine | |
| Clinical data | |
| |
| Identifiers | |
| 441-61-2 | |
| None | |
| PubChem | CID 46424 |
| DrugBank |
DB01468  |
| ChemSpider |
42256 |
| UNII |
722BFZ899Q |
| Chemical data | |
| Formula | C15H19NS2 |
| 277.45 g/mol | |
|
SMILES
| |
| |
| (what is this?) (verify) | |
Ethylmethylthiambutene (N-ethyl-N-methyl-1-methyl-3,3-di-2-thienylallylamine; Emethibutin) is an opioid analgesic drug from the thiambutene family, around 1.3x the potency of morphine.[1][2][3] It is under international control under Schedule I of the UN Single Convention On Narcotic Drugs 1961, presumably due to high abuse potential. It is a Schedule I controlled substance in the United States with a DEA ACSCN of 9623 and zero annual manufacturing quota as of 2013.
References
- ↑ Adamson, DW; Green, AF (1950). "A new series of analgesics". Nature 165 (4186): 122–122. doi:10.1038/165122a0. PMID 15409854.
- ↑ Adamson, DW; Duffin, WM; Green, AF (1951). "Dithienylbutylamines as analgesics". Nature 167 (4239): 153–4. doi:10.1038/167153b0. PMID 14806409.
- ↑ Green, AF (1953). "Analgesic and other properties of 3: 3-dithienylalkenylamines". British journal of pharmacology and chemotherapy 8 (1): 2–9. doi:10.1111/j.1476-5381.1953.tb00739.x. PMC 1509239. PMID 13066683.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||